GNRH1 and neoplasm: The MDA-MB-231 tumor growth was found to be reduced by 54.1% in response to Pt-Mal-LHRH 10 mg/kg treatment, whereas carboplatin 10mg/kg led to only a 32% reduction (Fig 4).